Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups

BMC Gastroenterology

Table 2 AST, ALT, and AST/ALT ratio distribution among Hiroshima residents who had abdominal ultrasonography during check-up

	N	AST (IU/L)				ALT (IU/L)				AST/ALT (AAR)
	N	Mean ± SD	Median	Min–max	AST ≥ 30 IU/L (%)	Mean ± SD	Median	Min–max	ALT ≥ 30 IU/L (%)	Mean ± SD	Median	Min–max	ALT/ALT > 1.0 (%)
Total population who received ultrasonography	5999	23.4 ± 12.0	21	8–363	15.4%	26.2 ± 20.6	20	2–503	26.5%	1.06 ± 0.39	1.0	0.26–7	47.8%
Non-drinkers without fatty liver	3781	20.9 ± 9.8*	19	8–363	7.6%^#	20.6 ± 14.6*	18	2–503	13.4%^#	1.15 ± 0.39*	1.1	0.26–7	60.0%^#
Non-drinkers with fatty liver (NAFLD)	1399	28.0 ± 13.6*	25	11–167	30.8%^#	40.7 ± 26.2*	33	7–291	59.4%^#	0.78 ± 0.26*	0.73	0.34–2.47	14.8%^#
p value		< 0.0001*			< 0.0001^#	< 0.0001*			< 0.0001^#	< 0.0001*			< 0.0001^#

AST alanine aminotransferase, ALT asparate aminotransferase, AAR AST/ALT ratio, SD standard deviation, NAFLD non-alcoholic fatty liver disease;
*p value of the Wilcoxon test comparing the AST and ALT levels and AST/ALT ratios in non-drinkers without fatty liver and non-drinkers with fatty liver (NAFLD)
^#p value of the Chi-square test comparing the percentage of AST ≥ 30 IU/L, ALT ≥ 30 IU/L, and ALT/ALT > 1.0 in non-drinkers without fatty liver and non-drinkers with fatty liver (NAFLD)

ISSN: 1471-230X